Retention Implementation Guide
2.2.0 - ci-build

Retention Implementation Guide - Local Development build (v2.2.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Artifacts Summary
.... 2.1 Sex Codesystem
.... 2.2 Ethnicity Codesystem
.... 2.3 Country of residence Codesystem
.... 2.4 Marital Status Codesystem
.... 2.5 ABO blood group Codesystem
.... 2.6 Highest level of education Codesystem
.... 2.7 Employment status Codesystem
.... 2.8 Thyroid disease Codesystem
.... 2.9 Smoker Codesystem
.... 2.10 Severe alcohol intake Codesystem
.... 2.11 Cardiomyopathy Codesystem
.... 2.12 NYHA class Codesystem
.... 2.13 Previous coronary revascularization Codesystem
.... 2.14 Atrial fibrillation Codesystem
.... 2.15 Previous valvular intervention Codesystem
.... 2.16 Ventricular stimulation Codesystem
.... 2.17 Type of LVAD Codesystem
.... 2.18 Intention of LVAD Codesystem
.... 2.19 Stroke after LVAD Codesystem
.... 2.20 CMV risk profile Codesystem
.... 2.21 Previous rejection episodes Codesystem
.... 2.22 Allograft vasculopathy Codesystem
.... 2.23 Medication Adherence Codesystem
.... 2.24 Type of visit Codesystem
.... 2.25 Type death Codesystem
.... 2.26 Type of CV admission Codesystem
.... 2.27 Category Change Codesystem
.... 2.28 Type of rejection Codesystem
.... 2.29 Type of rejection treatment Codesystem
.... 2.30 Dyspnea Codesystem
.... 2.31 Angina Codesystem
.... 2.32 Jugular Venous Pressure Codesystem
.... 2.33 Peripheral edema Codesystem
.... 2.34 Evaluation Codesystem
.... 2.35 Conduction delay Codesystem
.... 2.36 Troponin Codesystem
.... 2.37 Severity Codesystem
.... 2.38 MR Aetiology Codesystem
.... 2.39 VAD alarm Codesystem
.... 2.40 CPET Codesystem
.... 2.41 Questionnaire Symptoms answers Codesystem
.... 2.42 Category Codesystem
.... 2.43 Medication Codesystem
.... 2.44 Helper Codesystem
.... 2.45 Retention Codesystem
.... 2.46 Patient Example
.... 2.47 Arterial Hypertension
.... 2.48 Dyslipidemia
.... 2.49 Diabetes Mellitus type 1
.... 2.50 Diabetes Mellitus type 2
.... 2.51 COPD
.... 2.52 Renal insufficiency
.... 2.53 Estimated glomerular filtration rate
.... 2.54 Cerebrovascular disease
.... 2.55 Peripheral artery disease
.... 2.56 Aortic aneurysm
.... 2.57 Venous thromboembolism / pulmonary embolism
.... 2.58 Carotid Artery Disease
.... 2.59 Cancer
.... 2.60 Anemia
.... 2.61 Thyroid disease
.... 2.62 Benign Prostatic hyperplasia
.... 2.63 Smoker
.... 2.64 Severe alcohol intake
.... 2.65 Date HF diagnosis
.... 2.66 Cardiomyopathy
.... 2.67 NYHA class
.... 2.68 Number of HF admissions during the previous year
.... 2.69 Date HF admission
.... 2.70 Coronary artery disease
.... 2.71 Previous coronary revascularization
.... 2.72 Brady-arrhythmias / AV block
.... 2.73 Ventricular tachycardia / Ventricular fibrillation / Resuscitated sudden death
.... 2.74 Atrial fibrillation
.... 2.75 ICD
.... 2.76 CRT
.... 2.77 Pacemaker
.... 2.78 Previous valvular intervention
.... 2.79 Previous cardiac surgery
.... 2.80 Ventricular stimulation
.... 2.81 Date LVAD implant
.... 2.82 Type of LVAD
.... 2.83 Intention of LVAD
.... 2.84 Stroke after LVAD implantation
.... 2.85 Date stroke
.... 2.86 Gastrointestinal bleeding after LVAD
.... 2.87 Date GI bleeding
.... 2.88 Driveline infections
.... 2.89 Date DL infection
.... 2.90 Right heart failure - One month after implantation
.... 2.91 Right heart failure - At the time of implantation
.... 2.92 Sustained ventricular tachicardia one month after implantation
.... 2.93 Date heart transplant
.... 2.94 CMV risk profile
.... 2.95 CMV infection after transplant
.... 2.96 Previous opportunistic infections
.... 2.97 Previous rejection episodes
.... 2.98 Previous antibody mediated rejection
.... 2.99 Allograft vasculopathy
.... 2.100 Diastolic blood pressure - BP device
.... 2.101 Systolic blood pressure - BP device
.... 2.102 Heart Rate - BP Device
.... 2.103 Heart Rate - Oximeter
.... 2.104 Heart Rate - Average - Smartwatch
.... 2.105 Heart Rate - Maximum - Smartwatch
.... 2.106 Heart Rate - Minimum - Smartwatch
.... 2.107 Peripheral capillary oxygen saturation - Oximeter
.... 2.108 Body weight - Weightscale
.... 2.109 Body Temperature - Smartphone
.... 2.110 Steps - Smartwatch
.... 2.111 Calories - Smartwatch
.... 2.112 Distance - Smartwatch
.... 2.113 Floors climbed - Smartwatch
.... 2.114 Deep sleep time - Smartwatch
.... 2.115 Light sleep time - Smartwatch
.... 2.116 REM sleep - Smartwatch
.... 2.117 Sleep interruptions - Smartwatch
.... 2.118 Medication adherence - Smartphone
.... 2.119 Patient Visit
.... 2.120 Event Death
.... 2.121 Event HF decompensation needing iv. Diuretic
.... 2.122 Event HF decompensation needing inotropes
.... 2.123 Event Heart failure related visit
.... 2.124 Event HF Admission
.... 2.125 Event CV admission other than HF
.... 2.126 Event Other non-CV admissions
.... 2.127 Event Other non-CV visit
.... 2.128 Event Patient category change
.... 2.129 Event Drive line infection
.... 2.130 Event Drive line Reinfection
.... 2.131 Event Infection in other LVAD components
.... 2.132 Event Included in heart transplant list due to drive line infections
.... 2.133 Event Rejection needing treatment in HT
.... 2.134 Event CMV infection requiring medical treatment
.... 2.135 Event Infection
.... 2.136 ACEi Captopril
.... 2.137 ACEi Cilazapril
.... 2.138 ACEi Enalapril
.... 2.139 ACEi Fosinopril
.... 2.140 ACEi Lisinopril
.... 2.141 ACEi Perindopril
.... 2.142 ACEi Quinapril
.... 2.143 ACEi Ramipril
.... 2.144 ACEi Trandolapril
.... 2.145 ARBs Candesartan
.... 2.146 ARBs Losartan
.... 2.147 ARBs Valsartan
.... 2.148 ARBs Olmesartan
.... 2.149 Sacubitril - Valsartan
.... 2.150 Beta-blocker Bisoprolol
.... 2.151 Beta-blocker Carvedilol
.... 2.152 Beta-blocker Metoprolol
.... 2.153 Beta-blocker Nebivolol
.... 2.154 MRA Spironolactone
.... 2.155 MRA Eplerenone
.... 2.156 SGLT2i Canagliflozin
.... 2.157 SGLT2i Dapagliflozin
.... 2.158 SGLT2i Empagliflozin
.... 2.159 SGLT2i Ertugliflozin
.... 2.160 SGLT2i Sotagliflozin
.... 2.161 Ivabradine
.... 2.162 Vericiguat
.... 2.163 Digoxin
.... 2.164 Vasodilators Hydralazine
.... 2.165 Vasodilators Isosorbide dinitrate
.... 2.166 Antiplatelets Aspirin
.... 2.167 Antiplatelets Clopidogrel
.... 2.168 Antiplatelets Prasugrel
.... 2.169 Antiplatelets Ticagrelor
.... 2.170 Anticoagulants Acenocoumarol
.... 2.171 Anticoagulants Apixaban
.... 2.172 Anticoagulants Dabigatran
.... 2.173 Anticoagulants Edoxaban
.... 2.174 Anticoagulants Rivaroxaban
.... 2.175 Anticoagulants Warfarin
.... 2.176 Anticoagulants Phenprocoumon
.... 2.177 Loop diuretics Bumetanide
.... 2.178 Loop diuretics Furosemide
.... 2.179 Loop diuretics Torasemide
.... 2.180 Thiazides Bendroflumethiazide
.... 2.181 Thiazides Chlortalidone
.... 2.182 Thiazides Hydrochlorothiazide
.... 2.183 Thiazides Metolazone
.... 2.184 Thiazides Indapamide
.... 2.185 Potassium sparing diuretics Amiloride
.... 2.186 Potassium sparing diuretics Triamterene
.... 2.187 Potassium supplements Citrate
.... 2.188 Potassium supplements Phosphate
.... 2.189 Potassium supplements Aspartate
.... 2.190 Potassium supplements Bicarbonate
.... 2.191 Potassium supplements Gluconate
.... 2.192 Potassium binders Sodium zirconium cyclosilicate
.... 2.193 Potassium binders Patiromer
.... 2.194 Potassium binders Sodium polystyrene sulfonate
.... 2.195 Statins Atorvastatin
.... 2.196 Statins Fluvastatin
.... 2.197 Statins Lovastatin
.... 2.198 Statins Pravastatin
.... 2.199 Statins Pitavastatin
.... 2.200 Statins Rosuvastatin
.... 2.201 Statins Simvastatin
.... 2.202 Ezetimibe
.... 2.203 Other Antihyperlipidemic Drugs Fibrates
.... 2.204 Other Antihyperlipidemic Drugs Fish oil
.... 2.205 Other Antihyperlipidemic Drugs PCSK9
.... 2.206 Calcium Channel Blockers Amlodipine
.... 2.207 Calcium Channel Blockers Diltiazem
.... 2.208 Calcium Channel Blockers Felodipine
.... 2.209 Calcium Channel Blockers Lacidipine
.... 2.210 Calcium Channel Blockers Nifedipine
.... 2.211 Calcium Channel Blockers Verapamil
.... 2.212 Amiodarone
.... 2.213 Other antiarrhythmics Flecainide
.... 2.214 Other antiarrhythmics Sotalol
.... 2.215 Other antiarrhythmics Mexiletine
.... 2.216 PPI
.... 2.217 Steroids Cortisone
.... 2.218 Steroids Dexamethasone
.... 2.219 Steroids Hydrocortisone
.... 2.220 Steroids Methylprednisolone
.... 2.221 Steroids Prednisolone
.... 2.222 Steroids Prednisone
.... 2.223 Tacrolimus Immediate release (Prograft)
.... 2.224 Tacrolimus Slow release (Advagraft)
.... 2.225 Tacrolimus Extended release (Envarsus)
.... 2.226 Everolimus
.... 2.227 Ciclosporin
.... 2.228 Mycophenolate mofetil
.... 2.229 Mycophenolate sodium
.... 2.230 Antibiotics
.... 2.231 Insulin
.... 2.232 Other Antidiabetics Metformin
.... 2.233 Other Antidiabetics Thiazolidinedione
.... 2.234 Other Antidiabetics Sulfonylurea
.... 2.235 Other Antidiabetics Glucagon-like peptide-1 receptor agonist
.... 2.236 Other Antidiabetics Dipeptidyl peptidase-4 inhibitors
.... 2.237 Other Antidiabetics Alpha-glucosidase inhibitor
.... 2.238 Other drugs
.... 2.239 Dyspnea - Clinical Data
.... 2.240 Angina
.... 2.241 Syncope
.... 2.242 Fatigue - Clinical Data
.... 2.243 Pulmonary rales
.... 2.244 Jugular venous vressure
.... 2.245 Pleural effusion
.... 2.246 Hepatomegaly
.... 2.247 Ascites
.... 2.248 Peripheral edema
.... 2.249 S3
.... 2.250 S4
.... 2.251 Peripheral hypoperfusion
.... 2.252 Peripheral capillary oxygen saturation - Clinical Data
.... 2.253 Body weight - Clinical Data
.... 2.254 Body Temperature - Clinical Data
.... 2.255 Diastolic blood pressure - Clinical Data
.... 2.256 Systolic blood pressure - Clinical Data
.... 2.257 Heart rate - Clinical Data
.... 2.258 Evaluation - Clinical Data
.... 2.259 Sinus rhythm
.... 2.260 Heart rate - ECG
.... 2.261 PQ - PR
.... 2.262 QRS
.... 2.263 QT
.... 2.264 Conduction delay
.... 2.265 Hemoglobin
.... 2.266 Haematocrit
.... 2.267 White Blood Cells
.... 2.268 Platelets
.... 2.269 Urea
.... 2.270 Creatinine
.... 2.271 Uric acid
.... 2.272 Glucose
.... 2.273 Sodium
.... 2.274 Potassium
.... 2.275 Magnesium
.... 2.276 Cholesterol
.... 2.277 Triglycerides
.... 2.278 HDL
.... 2.279 LDL
.... 2.280 ALAT
.... 2.281 ASAT
.... 2.282 gGT
.... 2.283 LDH
.... 2.284 ALP
.... 2.285 Tot prot
.... 2.286 ALB
.... 2.287 Nt pro BNP
.... 2.288 Tbil
.... 2.289 D-Dimer
.... 2.290 Fibrinogen
.... 2.291 INR
.... 2.292 CPK
.... 2.293 Troponin
.... 2.294 Calcium
.... 2.295 Phosphorus
.... 2.296 CRP
.... 2.297 PRCLT
.... 2.298 TSH
.... 2.299 fT3
.... 2.300 fT4
.... 2.301 B12
.... 2.302 Iron
.... 2.303 Ferritin
.... 2.304 Evaluation
.... 2.305 Echo date
.... 2.306 LVED diameter
.... 2.307 LVES diameter
.... 2.308 EF
.... 2.309 Basal right ventricle diameter
.... 2.310 TAPSE
.... 2.311 Fractional area change
.... 2.312 Left atrium diameter
.... 2.313 Right atrium area
.... 2.314 AR
.... 2.315 MR
.... 2.316 MR Aetiology
.... 2.317 TR
.... 2.318 AS
.... 2.319 MS
.... 2.320 TS
.... 2.321 RVSP
.... 2.322 Interventricular Septum Thickness
.... 2.323 Left ventricular Posterior wall thickness
.... 2.324 Aortic Root diameter
.... 2.325 Inferior Vena Cava (IVC)
.... 2.326 Cardiac index
.... 2.327 6MWT
.... 2.328 BORG
.... 2.329 Capillary oxygen saturation at beginning
.... 2.330 Capillary oxygen saturation at the end
.... 2.331 VAD flow - Measurement
.... 2.332 VAD speed - Measurement
.... 2.333 VAD PI - Measurement
.... 2.334 VAD power - Measurement
.... 2.335 VAD alarm - Measurement
.... 2.336 CPET
.... 2.337 O2 max
.... 2.338 E to CO2 slope
.... 2.339 METS
.... 2.340 RER
.... 2.341 Questionnaire Response Symptoms
.... 2.342 Questionnaire Response MoCA
.... 2.343 Questionnaire Response MNA
.... 2.344 Questionnaire Response KCCQ
.... 2.345 Questionnaire Response PHQ-9
.... 2.346 Questionnaire Response CBQ-HF
.... 2.347 Questionnaire Response HF-CQ-5
.... 2.348 Patient Retention
.... 2.349 Patient Sex
.... 2.350 Patient Ethnicity
.... 2.351 Patient Country of residence
.... 2.352 Patient Marital Status
.... 2.353 Patient Height
.... 2.354 Patient ABO blood group
.... 2.355 Patient Highest level of education
.... 2.356 Patient Employment status
.... 2.357 Questionnaire Symptoms
.... 2.358 Questionnaire MoCA
.... 2.359 Questionnaire MNA
.... 2.360 Questionnaire KCCQ
.... 2.361 Questionnaire PHQ-9
.... 2.362 Questionnaire CBQHF
.... 2.363 Questionnaire HFCQ5